Microalbuminuria: marker of vascular dysfunction, risk factor for cardiovascular disease

Garg, Jay P; Bakris, George L
February 2002
Vascular Medicine;2002, Vol. 7 Issue 1, p35
Academic Journal
Based on the data from large single and multi-center clinical trials, including the Heart Outcomes Prevention Evaluation (HOPE) study, it is clear that the presence of microalbuminuria is a signal from the kidney that cardiovascular risk is increased and that vascular responses are altered. This is exemplified by studies that have demonstrated that the compensatory vasodilation seen following relief from prolonged ischemia or infusion of vasodilators such as nitroglycerin is blunted in people with microalbuminuria. Thus, the presence of between 30 and 299 mg/day of albumin in the urine is associated with abnormal vascular responsiveness, which may be the result of more advanced atherosclerosis and not necessarily related to the presence of hypertension or renal disease. Agents known to reduce the rise in microalbuminuria or actually reduce the level of microalbuminuria, such as ACE inhibitors, angiotensin receptor blockers, HMG-CoA reductase inhibitors, beta blockers, non-dihydropyridine calcium channel blockers and diuretics, have all been shown to reduce cardiovascular mortality and in some cases preserve renal function. This article will present an overview of the data that support the assertion that a reduction in the rise of microalbuminuria is a significant consideration in the selection of agents to treat a given risk factor (cholesterol or blood pressure) to a recommended target goal. Achieving such a goal with agents that also impact microalbuminuria will provide for a more complete cardiovascular risk reduction.


Related Articles

  • Microalbuminuria: associations with height and sex in non-diabetic subjects. Gould, M.M.; Mohamed-Ali, V.; Goubet, S.A.; Yudkin, J.S.; Haines, A.P. // BMJ: British Medical Journal (International Edition);1/23/93, Vol. 306 Issue 6872, p240 

    Examines the association between microalbuminuria and cardiovascular risk factors in non-diabetic patients in London, England. Assessment of urinary albumin excretion rate; Association of systolic pressure with albumin excretion rate; Prevalence of the disease among male populations.

  • Correlates of Urinary Albumin Excretion in Young Adult Blacks and Whites. Maureen A. Murtaugh; David R. Jacobs; Xinhua Yu; Myron D. Gross; Michael Steffes // American Journal of Epidemiology;10/1/2003, Vol. 158 Issue 7, p676 

    The rate of urinary albumin excretion is an important risk factor for kidney failure, stroke, and cardiovascular disease, perhaps because higher albumin excretion reflects endothelial cell dysfunction. The authors characterized urinary albumin excretion according to blood pressure, diabetes...

  • Microalbuminuria in essential hypertension. Crippa, G // Journal of Human Hypertension;Mar2002 Supplement, Vol. 16 Issue 3, pS74 

    Microalbuminuria (urinary albumin excretion equal to 30-300 mg/24 h) is a reliable indicator of premature cardiovascular mortality in diabetic patients and in the general population. In insulin-dependent and non-insulin-dependent diabetes mellitus microalbuminuria is a marker of initial diabetic...

  • Cross-sectional and longitudinal predictors of serum albumin in hemodialysis patients. Leavey, Sean F.; Strawderman, Robert L.; Young, Eric W.; Saran, Rajiv; Roys, Eric; Agodoa, Lawrence Y.C.; Wolfe, Robert A.; Port, Friedrich K. // Kidney International;Nov2000, Vol. 58 Issue 5, p2119 

    Studies the cross-sectional and longitudinal predictors of serum albumin in hemodialysis (HD) patients in the United States. Changes of albumin synthesis rate; Effect of the increase generation of fixed acids; Linkage between hypoalbuminemia and cardiovascular disease in HD patients.

  • Change of Serum Albumin and Risk of Cardiovascular Disease and All-Cause Mortality. Schalk, B. W. M.; Visser, M.; Bremmer, M. A.; Penninx, B. W. J. H.; Bouter, L. M.; Dee, D. J. H. // American Journal of Epidemiology;Nov2006, Vol. 164 Issue 10, p969 

    The aim of this longitudinal study was to investigate 3-year change in serum albumin concentration as a determinant of incident cardiovascular disease (CVD) and all-cause mortality. Data were from 713 respondents of the Longitudinal Aging Study Amsterdam initially aged 55–85 years. Serum...

  • Laparoskopik kolesistektomi süresince Splanknik sahadaki hemodinamik deÄŸiÅŸikliklerin deÄŸerlendirilmesinde iskemi modifiye albuminin rolü. Köksal, Hande; Kurban, Sevil; Şahin, Mustafa // Turkish Journal of Surgery / Ulusal Cerrahi Dergisi;2010, Vol. 26 Issue 2, p91 

    Purpose: Elevation of intraabdominal pressure by means of gas insufflation produces hemodynamic disturbances in the peritoneal viscera, leading to splanchnic ischemia. Recently, ischemia modified albumin (IMA) has been used to investigate conditions such as myocardial and skeletal muscle...

  • Evolución del índice de resistencia a darbepoetina alfa en pacientes dializados que cambian de administración semanal a quincenal en la práctica clínica. López-Gómez, J. M.; de Francisco, A. L. Martín; Montenegro, J.; de Santiago, C.; Vera, M.; Donapetry, C.; Villaverde, M. // Nefrologia;Feb2010, Vol. 30 Issue 1, p64 

    Background: Darbepoetin alfa (DA) administered every-other-week (Q2W) is efficacious and safe for the treatment of anaemia in patients undergoing dialysis. There are no data available regarding the evolution of erythropoietic resistance index (ERI) after conversion from weekly (QW) to Q2W...

  • Use of urine specific gravity to improve screening for albuminuria. Moore Jr., Richard R.; Hirata-Dulas, Cheryl A.; Kasiske, Bertram L. // Kidney International;Jul1997, Vol. 52 Issue 1, p240 

    The article focuses on the use of urine specific gravity to improve screening for albuminuria. The measurement of urine albumin excretion is becoming an increasingly important tool for clinicians. The detection of microalbuminuria, for example, is a useful predictor of subsequent nephropathy in...

  • p-Cresyl sulfate serum concentrations in haemodialysis patients are reduced by the prebiotic oligofructose-enriched inulin. Meijers, Björn K. I.; De Preter, Vicky; Verbeke, Kristin; Vanrenterghem, Yves; Evenepoel, Pieter // Nephrology Dialysis Transplantation;Jan2010, Vol. 25 Issue 1, p219 

    Introduction. Protein-bound uraemic retention solutes, including p-cresyl sulfate and indoxyl sulfate, contribute substantially to the uraemic syndrome. These and several other uraemic retention solutes originate from intestinal bacterial protein fermentation. We investigated whether the...

  • The predictive value of albuminuria for renal and nonrenal natural deaths over 14 years follow-up in a remote aboriginal community. Wang, Zaimin; Hoy, Wendy E. // Clinical Kidney Journal;Dec2012, Vol. 5 Issue 6, p519 

    Background Australian aboriginal people living in remote regions have extraordinary higher rates of mortality compared with other Australian ethnicities. Albuminuria marks the underlying renal disease. This study assessed the predictive value of albuminuria for nonrenal and renal deaths in a...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics